Login to Your Account

FDA Mulls Alternative Approval Path, Feedback Mostly Positive

By Catherine Shaffer
Staff Writer

Monday, February 4, 2013
The FDA convened a public hearing to receive input on its proposal to expedite development of new drugs for serious or life-threatening conditions with unmet need. The pathway would involve smaller, faster clinical trials with narrow, tightly enforced labeling for use in patients without other options.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription